
Recognition
Biocon Biologics is a fully integrated, global biosimilars player with a unique portfolio of high-quality affordable therapeutics spanning insulins, monoclonal antibodies (mAbs) and fusion proteins. Inspired by our promise of ‘Transforming Healthcare. Transforming Lives’, we leverage cutting-edge science, innovative tech platforms and global-scale manufacturing, to deliver life-changing medicines that lower the burden of care.
2025

Biocon Biologics wins Data Privacy Program of the Year Award at BW Tech Excellence Awards 2025
This prestigious recognition by BW Businessworld honors the Company’s continuous investment in embedding data privacy governance across all levels of operation.

Biocon Biologics wins Bioprocessing Excellence in South Asia Award at the Asia Pacific Biopharma Excellence Awards (ABEA) 2025.
The recognition highlights our outstanding contributions to advancing biopharma excellence in the Asia-Pacific region and beyond, and our cutting-edge technologies that have driven innovation and excellence.

Biocon Biologics wins National IP Award from Govt of India
We received the award in the category, Top Indian Company for creating Brand in India and Abroad, from the Government of India, Intellectual Property Office. The award came with a cash prize of Rs 1 lakh.

Biocon Biologics wins Best Patent Award 2021-2024 from IDMA
We earned this prestigious honor from the Indian Drug Manufacturers’ Association (IDMA) for our Insulin Glargine patent and a large portfolio of 86 patents belonging to 20 patent families globally.

Biocon Biologics wins Platinum award for Best Safety Excellence at the Green Enviro Foundation Awards
We won in the biopharmaceutical category. The award is an acknowledgement of the operations and systems we have put in place and their impact on the safety of employees and the society.

Biologics receives the DSCI Excellence Award for Best Privacy Practices in Organizations
This coveted award, given by the Data Security Council of India (DSCI), recognized our best practices and innovative strategies in data protection and privacy. We were honored in the “Best Privacy Practices in Data Fiduciaries” category.

Biocon Biologics wins the IFR Asia Award 2024 for High-Yield Bond.
The prestigious award honours the strategic refinancing of our long-term acquisition debt through a $800 million bond issuance, the largest issuance by any Indian pharma company in the past 10 years.
2024

Biocon Malaysia wins Company of the Year at Sustainability & CSR Malaysia Awards 2024
Biocon Sdn. Bhd. was chosen in the Outstanding Sustainable Environmental Initiatives category. The awards are a recognition of Biocon Biologics’ continuous investment in responsible and sustainable business practices that help create a healthier planet.

Biocon Biologics receives EHS Best Practices Award from Greentech Foundation
The Biocon Biologics Environment Health & Safety team is honored with the EHS Best Practices Global Award at the 1st Annual Greentech Global EHS Awards & Summit 2024. We were chosen among 100 companies that participated in the prestigious event.

Biocon Biologics wins the Prix Galien India Award for Best Medical Technology
The award, considered the Nobel Prize in pharmaceutical innovation, recognizes Biocon Biologics’ Pichia Pastoris Platform and its outstanding contribution to improving patient lives.

Biocon Biologics receives ‘Most Promising Biologics Drug Pipeline’ award
Biocon Biologics receives the prestigious ‘Most Promising Biologics Drug Pipeline’ award at the Biopharma Excellence Awards (BEA) India Edition 2024, hosted by IMAPAC.

Biocon Biologics receives ‘Most Promising Biologics Drug Pipeline’ award
Biocon Biologics receives the prestigious ‘Most Promising Biologics Drug Pipeline’ award at the Biopharma Excellence Awards (BEA) India Edition 2024, hosted by IMAPAC.
2023

Biocon Biologics recognized as an Asia IP Elite for 2023, IPR team adjudged Team of the Year
Biocon Biologics is recognized as an Asia IP Elite for 2023 by IAM (Intellectual Asset Management), the world’s biggest IP publication. Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year’s list. In addition, the Company’s IPR team is adjudged the ‘Healthcare and Biotechnology Team of the Year’ from Asia, for 2023.

Special Appreciation IP Award 2023 at CII International Conference
Biocon Biologics is conferred the Special Appreciation IP Award, 2023 by the Confederation of Indian Industry (CII) at the 9th International Conference on Intellectual Property Rights. The award recognizes our robust in-house IP strategies, and our global portfolio of patents and trademarks.

Twin Trophies at the IHW Patient First Awards 2023
Biocon Biologics bags a Gold for its Patient Support Program in Diabetology (BRIDGE-1) and a Silver for its Patient Support Program in Kidney Health (Parichay) at the prestigious IHW Patient First Awards 2023. Our Patient Support Programs have proved to be an invaluable tool in improving patient outcomes. The IHW awards are a testament to our unwavering dedication to transforming patient lives across the world.

Among ‘100 Best Companies for Women’ and ‘Top 100 Exemplar of Inclusion’
Biocon Biologics is recognized among the ‘100 Best Companies for Women’ and the ‘Top 100 Exemplar of Inclusion’ category in India at the Avtar & Seramount Best of the Best Conference 2023, for the sixth time in a row. This also puts us in the Top 100 Hall of Fame.

Global Generics and Biosimilars Award for acquisition of Viatris’ biosimilars business
Biocon Biologics wins the Acquisition of the Year Award at the Global Generics and Biosimilars Awards, 2023, for its landmark acquisition of the global biosimilars business of its partner, Viatris Inc. The award is given by Citeline, which provides pharmaceutical business intelligence tools and solutions, enabling the healthcare industry to strengthen its connection with patients.

LIFE AT WORK Award for Sustainability & DEI in Malaysia
Biocon Biologics is recognized by the LIFE AT WORK Awards (LAWA) as one of the Top 3 companies for Sustainability & DEI in Malaysia. LAWA is an annual event held by TalentCorp Malaysia that celebrates employers with progressive workplace strategies, demonstrating their commitment to the Diversity, Equity & Inclusion (DEI) agenda, in line with the demands of the Future of Work, Workplace, and Workforce.

Corporate Excellence Award at the Making India Employable Conference & Awards, 2023
Biocon Biologics wins the ‘Corporate Excellence Award’ in recognition of innovative strategies in hiring and onboarding fresh graduates, thereby facilitating a smooth transition from academia to industry, accelerating their career growth, and contributing to the Company’s growth.

Award for Bioprocessing Excellence in South Asia
Biocon Biologics is conferred with the prestigious ‘Bioprocessing Excellence in South Asia’ Award at the IMAPAC Asia-Pacific Bioprocessing Excellence Awards 2023. The awards recognize exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost, and superior quality.

Gold – 4 Star Excellence Award from World Safety Organization
Biocon Biologics receives the World Safety Organisation Outstanding Performance Award in the category of Workplace Occupational Health, Safety and Environment (OHS&E).

In-House Team of The Year – Pharma, Biotech
The Biocon Biologics Global Communications Team, led by Seema Ahuja, wins at the prestigious PRmoment Health Comms Awards 2023.

21st Greentech Safety Award 2023
Biocon Biologics is conferred with the ‘21st Greentech Safety Award 2023’ for outstanding achievement in ‘Safety Excellence’ at the Safety India Summit organized by Greentech Foundation.

Silver Award for ‘Sheinspires’ brand campaign
The Biocon Biologics Global Communications Team wins a Silver Award for the ‘SheInspires’ corporate brand campaign, at the 13th India PR and Corporate Communications Awards (IPRCCA).

Among India’s Top Corporate Communications Teams
The Global Communications Team is sixth among India’s Top Corporate Communications Teams, also marking the seventh consecutive year of ranking.

Biopharma Excellence Awards 2023, India Edition
Biocon Group (including Biocon Biologics and Syngene) is conferred with several awards at the prestigious Biopharma Excellence Awards 2023 India Edition, at the IMAPAC Biopharma Awards.
2022

22nd Greentech Environmental Award
Biocon Biologics is recognised for excellence and best practices in Sustainability and Environment Management.

Recognition by Malaysia Book of Records
Biocon Biologics Malaysia’s 562,000 sq ft facility is recognized as the first and largest integrated insulin manufacturer in Malaysia by Malaysia Book of Records.

Pharmaceutical In-House Legal Team of the Year
Biocon Biologics is conferred with the prestigious Legal Era Award for 2021-22.

Among Reputation Today’s Top 10 Corporate Communication Teams
The Group Communications Team moves up to No. 7 in Reputation Today’s Top 30 Corporate Communication Teams of the country.

L&D Innovation in Skill Development Award
Biocon Biologics is recognised for its patient-centric culture, taking a step forward with the success of the Hospital Staff Training Program targeted at external stakeholders from the medical fraternity.
2021

UN Women India WEPs Awards – 2021
Biocon is the India WEPs Awards Winner in the ‘Transparency and Reporting’ category (Gender Diversity), at the UN Women India WEPs Awards- 2021.

Among India’s Top 10 Best Workplaces
Biocon Biologics is certified one of the Top 10 – India’s Best Workplaces in Diversity, Equity, and Inclusion 2021, by Great Place to Work® India.

Unnatha Suraksha Puraskara
Biocon Biologics is conferred with the ‘Unnatha Suraksha Puraskara’ from the National Safety Council (NSC), Karnataka Chapter.

Group Communications Team Ranks No. 7 in India
The Biocon Group Communications Team moves up to No. 7 in Reputation Today’s Top 30 Corporate Communication Teams of the country.

2021 Facility of the Year (FOYA)
Biocon Biologics’ new monoclonal antibodies drugs substances manufacturing
facility wins the International Society for Pharmaceutical Engineering 2021 ‘Facility of the Year Honorable Mention Award’.

Top Indian Company at National IP Awards 2020
Biocon Biologics wins the prestigious National IP Awards 2020 for the first time, for creating ‘Brand in India and Abroad’. The award is conferred by the Government of India, Intellectual Property Office, under the Department for Promotion of Industry and Internal Trade.

